At a conference on Sunday, the Government's Open Source Drug Discovery (OSDD) initiative released the findings of its 'Connect 2 Decode' (C2D) project to re-annotate the biological and genetic data concerning the Mycobacterium tuberculosis (Mtb) genome.
This is the first time that a complete mapping of the Mtb genome has been accumulated, confirmed and made available publicly. C2D's results might include significant information to release previously unnoticed aspects of tuberculosis (TB); consequential in development opportunities for immediately required new TB drugs in India and other developing nations.
The World Health Organization (WHO) states that every year, 1.7 million people die from TB and that in some parts of the globe, one in four people with TB has a form of the disease, which can no longer be cured with ordinary drugs procedures. In spite of this public health emergency, TB research endowment, principally for new drugs, remains alarmingly insufficient.
Dr. Samir K. Brahmachari, Scientist and Director-General of the Council of Scientific and Industrial Research (CSIR), said, "We need to have a balanced view between health as a right and health as a business. It is because there has been imbalance in this view that diseases like TB, with high mortality but low profitability, are neglected by the current system of pharmaceutical research".
Loon Gangte of the Delhi Network of Positive People, a support group for people living with HIV/AIDS, said that the irony is that with the accessibility of medications for HIV and principally of safe and reasonable Indian standards, people are living with HIV but dying of TB.
http://topnews.us/content/216413-findings-c2d-project
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment